Methylphenidate Increases Cortical Excitability via Activation of Alpha-2 Noradrenergic Receptors
Open accessAbstract
Although methylphenidate (MPH), a catecholaminergic reuptake blocker, is prescribed for attention-deficit/hyperactivity disorder, there is a dearth of information regarding the cellular basis of its actions. To address this issue, we used whole-cell patch-clamp recordings to investigate the roles of various catecholamine receptors in MPH-induced changes in cortical neuron excitability. We bath-applied dopamine or noradrenaline receptor antagonists in combination with MPH to pyramidal cells located in deep layers of the infralimbic and prelimbic prefrontal cortices. Application of MPH (10 microM) by itself increased cortical cell excitability in slices obtained from juvenile rats. This MPH-mediated increase in excitability was lost when catecholamines were depleted with reserpine prior to recording, demonstrating the requirement for a presynaptic monoamine component. Antagonist studies further revealed that stimulation of alpha-2 noradrenergic receptors mediates the MPH-induced increase in intrinsic excitability. Dopamine D1 receptors played no observable role in the actions of MPH. We therefore propose that MPH is acting to increase catecholaminergic tone in the PFC, and thereby increases cortical excitability by mediating the disinhibition of pyramidal cells through mechanisms that may include activation of alpha-2 adrenoreceptors located in interneurons.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methylphenidate directly interacts with adrenergic receptors, and through α2 adrenergic receptor activation it stimulates cortical excitability.
“Multiple studies have demonstrated that MPH also directly interacts with adrenergic receptors (109, 115, 119, 120). Through activation of α2 adrenergic receptors, MPH has been demonstrated to stimulate cortical excitability (109).”
MPH exerts excitatory actions on PFC neurons by activating ADRA2.
“Moreover, it has been shown that MPH exerts excitatory actions on PFC neurons by activating ADRA2 [175, 176].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [176]
Cites
Regional and cellular fractionation of working memory
Goldman‐Rakic, P. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13473 · Cited by 810 · see citing works
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677 · see citing works
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608 · cited 1× · see citing works
“Moreover, MPH improves WM performance in healthy subjects (Elliot et al, 1997; Mehta et al, 2000) and several studies have shown that MPH increases overall speed and accuracy of attentional process in normal adults (Strauss et al, 1984; Solanto, 1998).”
BackgroundDopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
Arnsten, A. F. T., Cai, J. X., Murphy, B. L., & Goldman-Rakic, P. S. (1994) · Psychopharmacology · doi:10.1007/bf02245056 · Cited by 566 · see citing works
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 446 · see citing works
Carlsson, A., Fuxé, K., Hamberger, B., & Lindqvist, M. (1966) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1966.tb03334.x · Cited by 412 · see citing works
Effects of methylphenidate on spatial working memory and planning in healthy young adults
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050284 · Cited by 389 · see citing works
Yang, C., & Seamans, J. K. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01922.1996 · Cited by 369 · see citing works
Porrino, L. J., & Goldman, P. S. (1982) · The Journal of Comparative Neurology · doi:10.1002/cne.902050107 · Cited by 363 · see citing works
Amphetamine and Related Compounds
Cole, M. (2003) · Analytical techniques in the sciences · doi:10.1002/0470868007.ch2 · Cited by 326 · see citing works
Lewis, D., Campbell, M., Foote, S., Goldstein, M., & Morrison, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-01-00279.1987 · Cited by 325 · see citing works
Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 303 · see citing works
Lewis, B. L. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.12.1168 · Cited by 287 · see citing works
Williams, J., Henderson, G., & North, R. A. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90166-6 · Cited by 262 · see citing works
Arnsten, A. F. T., Cai, J., Steere, J. C., & Goldman-Rakic, P. S. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03429.1995 · Cited by 254 · see citing works
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252 · see citing works
A Neurocomputational Theory of the Dopaminergic Modulation of Working Memory Functions
Durstewitz, D., Kelc, M., & Güntürkün, O. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02807.1999 · Cited by 226 · see citing works
Perikaryal and synaptic localization ofα2A-adrenergic receptor-like immunoreactivity
Aoki, C. J., Go, C.-G., Venkatesan, C., & Kurose, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91782-5 · Cited by 221 · see citing works
The dopamine mesocorticolimbic pathway is affected by deficiency in n−3 polyunsaturated fatty acids
Zimmer, L., Vancassel, S., Cantagrel, S., Breton, P., Delamanche, S., Guilloteau, D., Durand, G., & Chalon, S. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.662 · Cited by 218 · see citing works
Noradrenaline‐mediated synaptic inhibition in rat locus coeruleus neurones.
Egan, T. M., Henderson, G., North, R. A., & Williams, J. T. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014990 · Cited by 199 · see citing works
Sawaguchi, T., Matsumura, M., & Kubota, K. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.63.6.1401 · Cited by 199 · see citing works
Levitt, P., RAKIC, P. T., & Goldman‐Rakic, P. S. (1984) · The Journal of Comparative Neurology · doi:10.1002/cne.902270105 · Cited by 191 · see citing works
Prefrontal neurons in networks of executive memory
Fuster, J. M. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00258-0 · Cited by 166 · see citing works
Heeringa, M. J., & Abercrombie, E. D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010192.x · Cited by 144 · see citing works
Lewis, D. A., & Morrison, J. H. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902820302 · Cited by 131 · see citing works
Andrade, R., & Aghajanian, G. K. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02359.1985 · Cited by 130 · see citing works
Miner, L. H., Schroeter, S., Blakely, R., & Sesack, S. R. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10898 · Cited by 112 · see citing works
Strauss, J., Lewis, J. L., Klorman, R., Peloquin, L., Perlmutter, R. A., & Salzman, L. F. (1984) · Psychophysiology · doi:10.1111/j.1469-8986.1984.tb00247.x · Cited by 90 · see citing works
Lavı́n, A., & Grace, A. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00096-3 · Cited by 87 · see citing works
Rd, H. (1987) · PubMed · Cited by 85 · see citing works
Hunt, R. D., Cohen, D. J., Anderson, G. M., & Clark, L. R. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90415-6 · Cited by 60 · see citing works
Hendley, E. D., Snyder, S. H., Fauley, J. J., & LaPidus, J. B. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29320-x · Cited by 37 · see citing works
Ross, S. B. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13218.x · Cited by 29 · see citing works
Lacroix, D., & Ferron, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90658-9 · Cited by 23 · see citing works
SCHMOLESKY, M. T., Wang, Y., Creel, D. J., & Leventhal, A. G. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001113)427:2 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020 · see citing works
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777229 · Cited by 766 · see citing works
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631 · see citing works
Functional neuroanatomy of the central noradrenergic system
Szabadi, E. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113490326 · Cited by 337 · see citing works
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269 · see citing works
Adrenoceptors in brain: Cellular gene expression and effects on astrocytic metabolism and [Ca2+]i
Hertz, L., Lovatt, D., Goldman, S. A., & Nedergaard, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.019 · Cited by 234 · see citing works
Alcohol and the prefrontal cortex
Abernathy, K., Chandler, L. J., & Woodward, J. J. (2010) · International Review of Neurobiology · doi:10.1016/s0074-7742(10)91009-x · Cited by 196 · see citing works
Pharmacology of stimulants prohibited by the World Anti‐Doping Agency (WADA)
Docherty, J. R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.124 · Cited by 143 · see citing works
Genetics of attention-deficit hyperactivity disorder (ADHD).
Sharp, S., McQuillin, A., & Gurling, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.011 · Cited by 131 · see citing works
Carr, D. B., Andrews, G. D., Glen, W. B., & Lavı́n, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.141671 · Cited by 119 · see citing works
Self-citationPolanczyk, G. V., Zeni, C., Genro, J. P., Guimarães, A. P., Roman, T., Hutz, M. H., & Rohde, L. A. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.218 · Cited by 115 · see citing works
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD
Myer, N. M., Boland, J. R., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.234 · Cited by 91 · see citing works
Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
Froehlich, T. E., McGough, J., & Stein, M. (2010) · CNS Drugs · doi:10.2165/11530290-000000000-00000 · Cited by 91 · see citing works
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 90 · see citing works
Park, S., Cho, S.-C., Hong, Y., Oh, S., Kim, J.-W., Shin, M., Kim, B., Yoo, H., Cho, I.-H., & Bhang, S. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.012 · Cited by 78 · see citing works
Chen, L., Bohanick, J. D., Nishihara, M., Seamans, J. K., & Yang, C. R. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00317.2006 · Cited by 79 · see citing works
Update on 3-iodothyronamine and its neurological and metabolic actions
Zucchi, R., Accorroni, A., & Chiellini, G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00402 · Cited by 76 · see citing works
Layer- and area-specific actions of norepinephrine on cortical synaptic transmission
Salgado, H., Treviño, M., & Atzori, M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.033 · Cited by 71 · see citing works
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70 · see citing works
“The DRD1, DRD5, ADRA2A, ADRA2B and ADRA2C are activated downstream by LDX [155, 158, 159].”
BackgroundInfluentialBisagno, V., González, B., & Urbano, F. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.013 · Cited by 59 · see citing works
Event-based control of autonomic and emotional states by the anterior cingulate cortex
Seamans, J. K., & Floresco, S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.026 · Cited by 58 · see citing works
Farr, O. M., Zhang, S., Hu, S., Matuskey, D., Abdelghany, O., Malison, R. T., & Li, C.-S. R. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000674 · Cited by 57 · see citing works
Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons
Urban, K. R., Waterhouse, B. D., & Gao, W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.018 · Cited by 57 · see citing works
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 56 · see citing works
Performance Enhancing, Non-Prescription Use of Ritalin
Svetlov, S. I., Kobeissy, F. H., & Gold, M. S. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26n04_01 · Cited by 55 · see citing works
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Busardò, F., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150407225902 · Cited by 52 · see citing works
ADHD pharmacogenetics across the life cycle: New findings and perspectives
Bruxel, E. M., Akutagava-Martins, G. C., Salatino-Oliveira, A., Contini, V., Kieling, C., Hutz, M., & Rohde, L. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32240 · Cited by 44 · see citing works
Korostenskaja, M., Kičić, D., & Kähkönen, S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1065-8 · Cited by 50 · see citing works
Schlösser, R. G. M., Nenadić, I., Wagner, G., Zysset, S., Koch, K., & Sauer, H. (2009) · Synapse · doi:10.1002/syn.20621 · Cited by 44 · see citing works
Laurencin, C., Lancelot, S., Brosse, S., Mérida, I., Redouté, J., Greusard, E., Lamberet, L., Liotier, V., Bars, D. L., Costes, N., et al. (2023) · Brain · doi:10.1093/brain/awad338 · Cited by 43 · see citing works
Cannabinoid modulation of alpha2adrenergic receptor function in rodent medial prefrontal cortex
Cathel, A. M., Reyes, B. A. S., Wang, Q., Palma, J. D., Mackie, K., Bockstaele, E. J. V., & Kirby, L. G. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12690 · Cited by 43 · see citing works
Zhang, C.-L., Feng, Z.-J., Liu, Y., Ji, X.-H., Peng, J.-Y., Zhang, X.-H., Zhen, X.-C., & Li, B.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051910 · Cited by 41 · see citing works
Cheon, K.-A. A., Cho, D.-Y., Koo, M., Song, D., & Namkoong, K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.003 · Cited by 38 · see citing works
Grzelka, K., Kurowski, P. N., Gawlak, M., & Szulczyk, P. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00341 · Cited by 38 · see citing works
Gronier, B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.002 · Cited by 44 · see citing works
Nam, Y., Shin, E., Shin, S. W., Lim, Y. K., Jung, J. H., Lee, J. H., Ha, J. R., Chae, J. S., Ko, S. K., Jeong, J. H., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.046 · Cited by 35 · see citing works
Stevens, T., Sangkuhl, K., Brown, J. T., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000376 · Cited by 34 · see citing works
Sangal, R. B., Sangal, J. M., & Thorp, K. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.07.013 · Cited by 34 · see citing works
Reyes, B. A. S., Szot, P., Sikkema, C. L., Cathel, A. M., Kirby, L. G., & Bockstaele, E. J. V. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.016 · Cited by 34 · see citing works
Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder: From Cells to Circuits
Minzenberg, M. J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0128-7 · Cited by 41 · see citing works
Yang, L., Qian, Q., Liu, L., Li, H.-M., Faraone, S., & Wang, Y.-F. (2013) · Journal of neural transmission · doi:10.1007/s00702-012-0955-z · Cited by 35 · see citing works
Batalhão, I. G., Lima, D., Russi, A. P. M., Boscolo, C. N. P., da Silva, D. G. H., Pereira, T. S. B., Bainy, A. C. D., & de Almeida, E. A. (2019) · Fish Physiology and Biochemistry · doi:10.1007/s10695-019-00645-2 · Cited by 30 · see citing works
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_33-1 · Cited by 31 · see citing works
Effect of antidepressant drugs on the vmPFC-limbic circuitry
Chang, C. H., Chen, M. C., & Lu, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.010 · Cited by 30 · see citing works
Shim, S.-H., Yoon, H.-J., Bak, J., Hahn, S., & Kim, Y. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.007 · Cited by 29 · see citing works
Noradrenergic fiber sprouting and altered transduction in neuropathic prefrontal cortex
Matos, S. C., Zamfir, M., Longo, G., Ribeiro‐da‐Silva, A., & Séguéla, P. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1543-7 · Cited by 28 · see citing works
Kim, B.-N., Kim, J.-W., Hong, S.-B., Cho, S.-C., Shin, M., & Yoo, H. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-57 · Cited by 28 · see citing works
Chien, Y.-J., Chien, Y.-C., Liu, C.-T., Wu, H.-C., Chang, C.-Y., & Wu, M.-Y. (2019) · Brain Science · doi:10.3390/brainsci9110291 · Cited by 25 · see citing works
Mehta, R., Giri, S., & Mallick, B. N. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00222-1 · Cited by 24 · see citing works
Kim, B.-N., Kim, J.-W., Cummins, T. D. R., Bellgrove, M. A., Hawi, Z., Hong, S.-B., Yang, Y.-H., Kim, H.-J., Shin, M., Cho, S.-C., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828f9fc3 · Cited by 24 · see citing works
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23 · see citing works
Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast
Easton, N., Marshall, F. H., Marsden, C. A., & Fone, K. C. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.018 · Cited by 22 · see citing works
Cotterly, L. M., Beverley, J. A., Yano, M., & Steiner, H. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05570.x · Cited by 22 · see citing works
Yuan, D., Zhang, M., Huang, Y., Wang, X., Jiao, J., & Huang, Y. (2021) · Medicine · doi:10.1097/md.0000000000027858 · Cited by 21 · see citing works
Stress Response, Brain Noradrenergic System and Cognition
Winklewski, P. J., Radkowski, M., Wszędybył-Winklewska, M., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_204 · Cited by 21 · see citing works
Kamei, J., Hirose, N., Oka, T., Miyata, S., Saitoh, A., & Yamada, M. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061021 · Cited by 20 · see citing works
Cho, S.-C., Kim, B.-N., Cummins, T. D. R., Kim, J.-W., & Bellgrove, M. A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405356 · Cited by 19 · see citing works
García‐Oscos, F., Torres‐Ramírez, O., Dinh, L., Galindo‐Charles, L., Padilla, E. A. P., Pineda, J. C., Atzori, M., & Salgado, H. (2014) · Synapse · doi:10.1002/syn.21794 · Cited by 16 · see citing works
Gronier, B., James, A., Liauzun, C., & Zetterström, T. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359100 · Cited by 17 · see citing works
Kaneko, F., Kawahara, Y., Kishikawa, Y., Hanada, Y., Yamada, M., Kakuma, T., Kawahara, H., & Nishi, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw026 · Cited by 18 · see citing works
Lee, S. H., Kim, S. W., Lee, M. G., Yook, K.-H., Greenhill, L. L., Frandin, K. N., & Hong, H. J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.08.033 · Cited by 17 · see citing works
Hegvik, T., Jacobsen, K. K., Fredriksen, M., Zayats, T., & Haavik, J. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1540-7 · Cited by 17 · see citing works
Capuzzi, E., Caldiroli, A., Auxilia, A. M., Borgonovo, R., Capellazzi, M., Clerici, M., & Buoli, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101742 · Cited by 12 · see citing works
Reyes, B. A. S., Carvalho, A. F., Szot, P., Kalamarides, D. J., Wang, Q., Kirby, L. G., & Bockstaele, E. J. V. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.010 · Cited by 12 · see citing works
Lukkes, J. L., Freund, N., Thompson, B. S., Meda, S., & Andersen, S. L. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.06.003 · Cited by 11 · see citing works
The anterior cingulate cortex and event-based modulation of autonomic states
Seamans, J. K. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.006 · Cited by 10 · see citing works
Sex differences in μ-opioid regulation of coerulear-cortical transmission
Guajardo, H. M., & Valentino, R. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135651 · Cited by 10 · see citing works
Dafny, N., Claussen, C. M., & Witte, L. J. (2015) · Journal of Experimental Pharmacology · doi:10.2147/jep.s75300 · Cited by 9 · see citing works
Grünblatt, E., Bartl, J., Marinova, Z., & Walitza, S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0869-9 · Cited by 9 · see citing works
Bases genéticas del trastorno por déficit de atención/hiperactividad
Sánchez-Mora, C., Ribasés, M., Mulas, F., Soutullo, C., Sans, A., Pàmias, M., Casas, M., & Ramos-Quiroga, J. (2012) · Revista de Neurología · doi:10.33588/rn.5510.2012344 · Cited by 10 · see citing works
Ortega-Álvaro, A., Navarrete, F., Aracil-Fernández, A., Navarro, D., Berbel, P. J., & Manzanares, J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.113 · Cited by 8 · see citing works
A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory
Yang, Y., Lewis, M. M., Kong, L., & Mailman, R. B. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001215 · Cited by 7 · see citing works
Crump, C., Abuelazm, H., Ibrahim, K., Shah, S. R., & El‐Mallakh, R. S. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2367695 · Cited by 7 · see citing works
CRISPR/Cas9‐induced nos2b mutant zebrafish display behavioral abnormalities
Gao, L., Penglee, R., Huang, Y., Yi, X., Wang, X., Liu, L., Gong, X., & Bao, B. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12716 · Cited by 6 · see citing works
Dafny, N., & Claussen, C. M. (2014) · Journal of Experimental Pharmacology · doi:10.2147/jep.s53497 · Cited by 6 · see citing works
Probable Methylphenidate-Related Reversible “Visual Snow” in a Child With ADHD
Naguy, A., Naguy, C., & Singh, A. (2022) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000512 · Cited by 6 · see citing works
Yaoita, F., Tsuchiya, M., Arai, Y., Tadano, T., & Tan–No, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.002 · Cited by 6 · see citing works
Yaoita, F., Namura, K., Shibata, K., Sugawara, S., Tsuchiya, M., Tadano, T., & Tan–No, K. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00255 · Cited by 6 · see citing works
Navarra, R. L., & Waterhouse, B. D. (2018) · Brain Research · doi:10.1016/j.brainres.2018.06.027 · Cited by 5 · see citing works
Treating Attention Deficits and Impulse Control
Timmers, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396988-0.00006-4 · Cited by 5 · see citing works
Catecholaminergic Modulation of Semantic Processing in Sentence Comprehension
Tan, Y., & Peter Hagoort, A. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa204 · Cited by 4 · see citing works
Attention Deficit Hyperactivity Disorder
Marco, P., Maddalena, M., Bertella, S., Gatti, E., & Nobile, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00164-x · Cited by 4 · see citing works
Aloud real- time reading of intensive care unit diaries: A feasibility study
Johnson, K. R., Temeyer, J. P., Schulte, P. J., Nydahl, P., Philbrick, K. L., & Karnatovskaia, L. V. (2023) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2023.103400 · Cited by 4 · see citing works
Disciplined sleep for healthy living: Role of noradrenaline
Mehta, R., Singh, A., & Mallick, B. N. (2017) · World Journal of Neurology · doi:10.5316/wjn.v7.i1.6 · Cited by 4 · see citing works
The Treatment of Adult ADHD: Complexity at Hand
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_19 · Cited by 3 · see citing works
Methylphenidate modulates motor cortical dynamics and behaviorPreprint
Verhein, J. R., Vyas, S., & Shenoy, K. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.15.562405 · Cited by 3 · see citing works
Hodzhev, Y., Yordanova, J., Diruf, M., Kratz, O., Moll, G. H., Kolev, V., & Heinrich, H. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0799-6 · Cited by 3 · see citing works
Atzori, M., Salgado, H., & Tseng, K.-Y. (2007) · Springer eBooks · doi:10.1007/978-0-387-72256-6_13 · Cited by 2 · see citing works
Neurofibromatosis Type I Learning Disabilities
Shilyansky, C., Wiltgen, B. J., & Silva, A. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00019-x · Cited by 2 · see citing works
Pharmacogenomics of Attention-Deficit/Hyperactivity Disorder
Froehlich, T. E., & Stein, M. A. (2010) · Advances in biological psychiatry · doi:10.1159/000317300 · Cited by 1 · see citing works
Somkuwar, S. S. (2013) · UKnowledge (University of Kentucky)
Metilfenidato causa alterações neuroquímicas e comportamentais em ratos
Scherer, E. B. D. S. (2010) · Americanae (AECID Library)
AD(H)S, Körperkontaktstörung und Körperbezogene Interaktionstherapie (KIT)
Smikalla, W.-D. (2014) · Springer eBooks · doi:10.1007/978-3-642-41118-2_17
Gronier, B., Aston, J., Liauzun, C., & Zetterström, T. (2011)
Kaminski, M., & Sjøgren, P. (2008) · Via Medica Journals
Review of Select Sleep Medicine Pharmacology: Treatments of Hypersomnias and Parasomnia
Johnson, K., Mansukhani, M. P., & Kolla, B. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00163-8
Neurobiology and Genetics of Pair Bonding: A New HypothesisPreprint
Gadda, N. S. (2022) · doi:10.31219/osf.io/cvz58
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_33 · Cited by 1 · see citing works
Dynamic Routing on a Static Structure: Noradrenergic Gating of Cortical Wave PropagationPreprint
Maran, R., Shine, J. M., Fulcher, B., & Müller, E. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705210
- Authors
- Andrews, G. D., & Lavin, A.
- Affiliations
- Medical University of South Carolina (US)
- Venue
- Neuropsychopharmacology
- Published
- 2005-07-06
- Volume
- 31
- Issue
- 3
- Pages
- 594-601
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC5509071
- OpenAlex
- W2018418849
- Cited by
- 101
- References
- 36
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 9
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (14698)
- National Institute on Drug Abuse (R01DA014698, R56DA014698, DA 14698)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- methylphenidate, alpha2-adrenoceptors, cortical excitability, prefrontal cortex, pyramidal neurons, catecholamine depletion, reserpine, dopamine D1 receptor, norepinephrine, attention deficit hyperactivity disorder, disinhibition, interneurons
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic alpha-Antagonists, Central Nervous System Stimulants, Animals, Catecholamines, Cerebral Cortex, Dopamine, Electrophysiology, Male, Methylphenidate, Nerve Net, Norepinephrine, Prefrontal Cortex, Pyramidal Cells, Receptors, Adrenergic, alpha-2, Dopamine Agonists, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review